Luo Qinghua, Zhu Dan, Tan Anhui
Department of Anorectal, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei Province, China.
Medicine (Baltimore). 2025 Aug 8;104(32):e43756. doi: 10.1097/MD.0000000000043756.
Postoperative hemorrhage is the most common and potentially serious complication following anal surgery, increasing hospitalization time, healthcare costs, and patient morbidity. This study aimed to identify independent risk factors associated with postoperative bleeding in patients undergoing anorectal surgery. We conducted a retrospective cohort study of 150 patients who underwent anorectal surgery at our institution from January 1, 2020, to December 31, 2024. Clinical variables - including demographics, comorbidities, medication history, laboratory tests, surgical features, and perioperative management - were collected and analyzed. Postoperative bleeding was defined as persistent hemorrhage requiring intervention, hemoglobin decrease ≥ 20 g/L, transfusion, or reoperation within 30 days. Variables with P < .05 in univariate analysis were included in a forward stepwise logistic regression model. Among 150 patients who underwent anorectal surgery, postoperative bleeding occurred in 20 cases, yielding an incidence of 13.3%. Univariate analysis revealed that bleeding was significantly associated with use of anticoagulants (P = .002), more than 3 previous anorectal procedures (P = .014), thrombocytopenia (P = .006), elevated activated partial thromboplastin time (P = .018), trauma area > 10 cm2 (P = .004), and first postoperative bowel movement within 24 hours (P = .001). These variables were entered into a forward stepwise multivariate logistic regression model. The final model identified 5 independent predictors of bleeding: warfarin therapy (OR = 4.36; 95% CI = 1.85-7.82; P = .001), more than 3 prior anorectal surgeries (OR = 2.59; 95% CI = 1.72-4.28; P = .012), preoperative platelet count < 100 × 109/L (OR = 3.11; 95% CI = 1.50-5.62; P = .005), surgical trauma area > 10 cm2 (OR = 3.80; 95% CI = 1.47-6.45; P = .003), and first defecation within 24 hours after surgery (OR = 2.31; 95% CI = 1.10-4.16; P = .002). The Hosmer-Lemeshow test indicated good model fit (P = .472). Preoperative correction of coagulopathy, minimization of surgical trauma, and delayed bowel movements beyond 24 hours postoperatively may reduce the risk of postoperative hemorrhage. These findings offer guidance for individualized risk assessment and targeted preventive strategies in anorectal surgery.
术后出血是肛门手术后最常见且可能严重的并发症,会增加住院时间、医疗费用以及患者的发病率。本研究旨在确定接受肛肠手术患者术后出血的独立危险因素。我们对2020年1月1日至2024年12月31日在本机构接受肛肠手术的150例患者进行了一项回顾性队列研究。收集并分析了临床变量,包括人口统计学、合并症、用药史、实验室检查、手术特征和围手术期管理。术后出血定义为需要干预的持续性出血、血红蛋白下降≥20g/L、输血或在30天内再次手术。单因素分析中P<0.05的变量被纳入向前逐步逻辑回归模型。在150例接受肛肠手术的患者中,20例发生术后出血,发生率为13.3%。单因素分析显示,出血与使用抗凝剂(P=0.002)、既往肛肠手术超过3次(P=0.014)、血小板减少(P=0.006)、活化部分凝血活酶时间延长(P=0.018)、创伤面积>10cm²(P=0.004)以及术后24小时内首次排便(P=0.001)显著相关。这些变量被纳入向前逐步多变量逻辑回归模型。最终模型确定了5个出血的独立预测因素:华法林治疗(OR=4.36;95%CI=1.85-7.82;P=0.001)、既往肛肠手术超过3次(OR=2.59;95%CI=1.72-4.28;P=0.012)、术前血小板计数<100×10⁹/L(OR=3.11;95%CI=1.50-5.62;P=0.005)、手术创伤面积>10cm²(OR=3.80;95%CI=1.47-6.45;P=0.003)以及术后24小时内首次排便(OR=2.31;95%CI=1.10-4.16;P=0.002)。Hosmer-Lemeshow检验表明模型拟合良好(P=0.472)。术前纠正凝血功能障碍、尽量减少手术创伤以及术后排便延迟至24小时以后可能会降低术后出血的风险。这些发现为肛肠手术中的个体化风险评估和针对性预防策略提供了指导。